< Key Hightlight >

Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age.

The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Pneumococcal Polysaccharide Vaccine Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Pneumococcal Polysaccharide Vaccine market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

The report firstly introduced the Pneumococcal Polysaccharide Vaccine basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. 

The major players profiled in this report include:

Merck & Co., Inc.

Pfizer Inc.

Glaxosmithkline Plc.

Sanofi Pasteur

China National Biotec Group

Astellas Pharma Inc

Serum Institute of India Pvt. Ltd

……

The end users/applications and product categories analysis:

On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-

Single Dose Vial

Pre-Filled Syringe

……

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pneumococcal Polysaccharide Vaccine for each application, including-

Children (2-10 Age)

Adult (10-64 Age)

Geriatric (More Than 65 Age)

……